Industry push for global GCPs rule before FDA completes foreign study guidance
This article was originally published in Clinica
Executive Summary
Medical device manufacturers are concerned about a lack of globally harmonized standards for good clinical practices (GCPs), which they say could cause problems for a guidance that the FDA has drafted on studies conducted outside the US.